Real-World Evidence for Miach Orthopaedics’ BEAR® Implant Highlighted at AOSSM 2025

Medically reviewed by Dr. Sabrina Strickland, MD · Orthopedic Surgeon, Hospital for Special Surgery · Last reviewed: July 18, 2025

July 14, 2025

Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears with the BEAR® Implant, today announced the presentation of one- and two-year results of the Bridge Registry study at the recent American Orthopaedic Society for Sports Medicine (AOSSM) annual meeting.

Real-World Evidence for Miach Orthopaedics’ BEAR® Implant Highlighted at AOSSM 2025

Photo by CHUTTERSNAP on Unsplash

ACL tears, BEAR implant, Bridge Registry, real-world outcomes, retear rate

Considering treatment for a knee or shoulder concern?

Dr. Sabrina Strickland sees patients at Hospital for Special Surgery in New York City. If you would like a personalized evaluation of your symptoms and options, request a consultation below.

Book an appointment Contact the office

Medical Disclaimer. This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified physician regarding any questions about your orthopedic health. Individual results may vary based on diagnosis, anatomy, and overall health.